Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             125 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abuse-Deterrent Opioid Formulations: A Key Ingredient in the Recipe to Prevent Opioid Disasters? Salwan, Aaron J.
2018
7 p. 573-577
artikel
2 Acetazolamide and Cardiac Failure Cimolai, Nevio
2018
7 p. 649-650
artikel
3 Acid-Suppressive Therapy and Risk of Infections: Pros and Cons Fisher, Leon
2017
7 p. 587-624
artikel
4 Acid-Suppressive Therapy and Risk of Infections: Pros and Cons Fisher, Leon

7 p. 587-624
artikel
5 A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec Korsatko, Stefan
2013
7 p. 515-521
artikel
6 Acute Renal Failure, Ketoacidosis, and Urogenital Tract Infections with SGLT2 Inhibitors: Signal Detection Using a Japanese Spontaneous Reporting Database Katsuhara, Yukari

7 p. 645-652
artikel
7 Adherence to Antidepressants and Mortality in Elderly Patients with Cardiovascular Disease Biffi, Annalisa
2018
7 p. 593-602
artikel
8 Adverse Drug Reaction Profile of SGLT2 Inhibitor-Associated Diabetic Ketosis/Ketoacidosis in Singapore and their Precipitating Factors Limenta, Michael
2019
7 p. 683-690
artikel
9 Analysis of Clinical Predictors of Resolution of Sleep Disturbance Related to Frequent Nighttime Heartburn and Acid Regurgitation Symptoms in Individuals Taking Esomeprazole 20 mg or Placebo Johnson, David A.
2016
7 p. 531-538
artikel
10 An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA Bensimon, Arielle G.

7 p. 629-643
artikel
11 A Novel Once-Daily Fixed-Dose Combination of Memantine Extended Release and Donepezil for the Treatment of Moderate to Severe Alzheimer’s Disease: Two Phase I Studies in Healthy Volunteers Boinpally, Ramesh
2015
7 p. 427-435
artikel
12 An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19) Das, Saibal

7 p. 591-601
artikel
13 A Phase 1 Study to Evaluate the Drug Interaction Between Islatravir (MK-8591) and Doravirine in Adults Without HIV Matthews, Randolph P.

7 p. 629-638
artikel
14 A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease Jang, Eun Jin
2019
7 p. 625-630
artikel
15 Association Between Migraine and Ischemic Cardio-Cerebrovascular Disease (CCVD) and Effects of Triptans and Ergotamine on the Risk of Ischemic CCVD in Patients with Migraine in the Korean NHIS-HEALS Cohort Kim, Yonghwan

7 p. 541-550
artikel
16 A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population Shiroma, Paulo R.

7 p. 549-566
artikel
17 Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995 Murphy, Yoko
2016
7 p. 519-530
artikel
18 Blister-Packing of 2 mg Buprenorphine Monoproduct as a Patient-Centered Method of Microdosing for Buprenorphine Induction Accurso, Anthony J.

7 p. 663-664
artikel
19 Budesonide/Formoterol Maintenance and Reliever Therapy in Asian Patients (Aged ≥16 Years) with Asthma Vogelmeier, C.
2012
7 p. 439-449
artikel
20 Buprenorphine Microinduction: Logistical Barriers and the Need for Convergent Evidence De Aquino, Joao P.

7 p. 665
artikel
21 Clinical Pharmacokinetics of the Nicotinic Channel Modulator Dexmecamylamine (TC-5214) in Subjects with Various Degrees of Renal Impairment Alverlind, Sofie
2014
7 p. 457-465
artikel
22 Comment on ‘Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety’ Koren, Andrew

7 p. 659-660
artikel
23 Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial Mowla, Arash
2016
7 p. 539-543
artikel
24 Comparison of Health Services Use Associated with Ziprasidone and Olanzapine among Schizophrenia and Bipolar Disorder Patients in the USA Jiang, Yawen
2014
7 p. 491-499
artikel
25 Comparison of Safety Profiles of New Oral Anticoagulants with Warfarin Using the Japanese Spontaneous Reporting Database Hosohata, Keiko
2019
7 p. 665-670
artikel
26 Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials Song, Gwan Gyu
2019
7 p. 701
artikel
27 Correction to: Rifamycin SV MMX®: A Review in the Treatment of Traveller’s Diarrhoea Hoy, Sheridan M.
2019
7 p. 699
artikel
28 Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain Vennera, María del Carmen
2016
7 p. 567-578
artikel
29 Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan Mo, Xiuting

7 p. 599-609
artikel
30 Cost-Effectiveness of Fixed-Dose Combinations Therapies for Chronic Obstructive Pulmonary Disease Treatment Capel, Margarita
2018
7 p. 611-620
artikel
31 Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population Corey, Adam
2017
7 p. 625-634
artikel
32 Current Clinical Trials on the Use of Ceftaroline in the Pediatric Population Corey, Adam

7 p. 625-634
artikel
33 Current Topics in Opioid Therapy for Pain Management: Addressing the Problem of Abuse Casty, Frank E.
2013
7 p. 459-468
artikel
34 Developmental Changes in Morphine Clearance Across the Entire Paediatric Age Range are Best Described by a Bodyweight-Dependent Exponent Model Wang, Chenguang
2013
7 p. 523-534
artikel
35 Discomfort from an Alkaline Formulation Delivered Subcutaneously in Humans Ward, W. Kenneth
2012
7 p. 433-438
artikel
36 Disease Burden, Early Discontinuation, and Healthcare Costs in Hepatitis C Patients with and without Chronic Kidney Disease Treated with Interferon-Free Direct-Acting Antiviral Regimens Puenpatom, Amy
2017
7 p. 687-697
artikel
37 Dose-Dependent Effect of Landiolol, a New Ultra-Short-Acting β1-Blocker, on Supraventricular Tachyarrhythmias in Postoperative Patients Taenaka, Nobuyuki
2013
7 p. 505-514
artikel
38 Dose Recommendations for Common Drugs in Patients with Liver Cirrhosis: A Systematic Literature Review Karsten Dafonte, Katharina

7 p. 475-502
artikel
39 Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand Bamrungsawad, Naruemon
2016
7 p. 557-566
artikel
40 Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden Lundberg, Johan
2014
7 p. 483-489
artikel
41 Effectiveness of an Intervention to Improve Management of COPD using the AUDIT Methodology: Results of the Neumo-Advance Study de Miguel-Díez, Javier
2019
7 p. 653-664
artikel
42 Effect of Atorvastatin on Haemostasis, Fibrinolysis and Inflammation in Normocholesterolaemic Patients with Coronary Artery Disease Walter, Thomas
2010
7 p. 453-460
artikel
43 Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects Pena, María Ángeles

7 p. 617-628
artikel
44 Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects Trivedi, Ashit

7 p. 647-652
artikel
45 Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus Arase, Yoshitaka
2019
7 p. 631-641
artikel
46 Effects of AZD0837, a Novel Direct Thrombin Inhibitor, on the Electrophysiological Properties of the Human Heart Walfridsson, Håkan
2010
7 p. 461-471
artikel
47 Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients Sinha, Shubhadeep D.

7 p. 565-574
artikel
48 Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II Study Tampaki, Ekaterini C.
2018
7 p. 639-648
artikel
49 Efficacy of Interferon-Free Therapies for Chronic Hepatitis C: A Systematic Review of All Randomized Clinical Trials Ferreira, Vinicius L.
2017
7 p. 635-646
artikel
50 Elevations in Creatine Kinase are Not Related to the Choice or Dose of Statins in Patients Taking Colchicine 0.5 mg Daily: Insights from the LoDoCo2 Trial van Broekhoven, Amber

7 p. 575-577
artikel
51 Erratum to: Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future Amigoni, Angela
2017
7 p. 711
artikel
52 Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden Justo, Nahila

7 p. 529-540
artikel
53 Evaluation of Buprenorphine Dosage Adequacy in Opioid Receptor Agonist Substitution Therapy for Heroin Dependence D’Amore, Antonio
2012
7 p. 427-432
artikel
54 Evaluation of Pharmacokinetic and Pharmacodynamic Interactions when Lenalidomide is Co-administered with Warfarin in a Randomized Clinical Trial Setting Weiss, Daniel
2015
7 p. 455-461
artikel
55 Evaluation of the Pharmacokinetics and Pharmacodynamics of Prasugrel in Japanese Elderly Subjects Hasunuma, Tomoko
2017
7 p. 679-685
artikel
56 Exposure–Safety Response Relationship for Ombitasvir, Paritaprevir/Ritonavir, Dasabuvir, and Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Data from Five Phase II and Six Phase III Studies Lin, Chih-Wei
2017
7 p. 647-657
artikel
57 Expression of Concern to: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy Koren, Gideon

7 p. 681
artikel
58 Fixed or Adjustable Maintenance-Dose Budesonide/Formoterol Compared with Fixed Maintenance-Dose Salmeterol/Fluticasone Propionate in Asthma Patients Aged ≥16 Years Aalbers, René
2010
7 p. 439-451
artikel
59 Guillain–Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data Atzenhoffer, Marina

7 p. 581-592
artikel
60 Health Economic Analysis of Antiplatelet Therapy for Acute Coronary Syndromes in the Context of Five Eastern Asian Countries Wu, Bin
2018
7 p. 621-630
artikel
61 Impact of Anthracyclines on Diabetes Mellitus Development in B-Cell Lymphoma Patients: A Nationwide Population-based Study Teng, Chieh-Lin Jerry
2018
7 p. 603-610
artikel
62 Interventions and Strategies to Improve Oral Anticoagulant Use in Patients with Atrial Fibrillation: A Systematic Review of Systematic Reviews Ng, Siok Shen
2018
7 p. 579-591
artikel
63 Linking the Price of Cancer Drug Treatments to Their Clinical Value Gozzo, Lucia
2016
7 p. 579-589
artikel
64 Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies Sharma, Ashish
2017
7 p. 705-707
artikel
65 Long-term Renal Effects of Tenofovir-Disoproxil-Fumarate in Vertically HIV-Infected Children, Adolescents, and Young Adults: A 132-Month Follow-Up Study Giacomet, Vania
2015
7 p. 419-426
artikel
66 Maintenance Therapy in HER2-Negative Metastatic Breast Cancer: A New Approach for an Old Concept Ciruelos, Eva
2019
7 p. 595-606
artikel
67 Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence Yeganeh Salehpour, Mahshid
2019
7 p. 607-624
artikel
68 New Oral Anticoagulants for Thromboprophylaxis in Patients with Cancer Receiving Chemotherapy: An Economic Evaluation in a Chinese Setting Du, Jiangyang

7 p. 653-663
artikel
69 Observational Study of Intravenous Lacosamide in Patients with Convulsive Versus Non-Convulsive Status Epilepticus Moreno Morales, Eros Yamel
2015
7 p. 463-469
artikel
70 Observational Study on Dipeptidyl Peptidase-4 Inhibitors: A Real-Life Analysis on 360 Patients from the ASL VCO Territory in Italy Saglietti, Giuseppe
2014
7 p. 513-519
artikel
71 Oral Cyclo-Oxygenase 2 Inhibitors versus Other Oral Analgesics for Acute Soft Tissue Injury Jones, Peter
2010
7 p. 419-437
artikel
72 Oral Teicoplanin as an Alternative First-Line Regimen in Clostridium difficile Infection in Elderly Patients: A Case Series Davido, Benjamin
2017
7 p. 699-703
artikel
73 Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis Brown, Mark T.

7 p. 551-563
artikel
74 Pharmacokinetic and Exposure–Response Analyses of Leuprolide Following Administration of Leuprolide Acetate 3-Month Depot Formulations to Children with Central Precocious Puberty Mostafa, Nael M.
2014
7 p. 441-448
artikel
75 Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects Shen, Qi

7 p. 623-630
artikel
76 Pharmacokinetics of a New Immediate-Release Methadone Tablet Formulation with Decreased In vitro Solubility Vinson, Robert K.
2012
7 p. 487-495
artikel
77 Pharmacokinetics of Anti-tuberculous Drugs Delivered Via Nasogastric Tube Feeding in a Critically Ill Patient: A Case Study Alsultan, Abdullah

7 p. 675-678
artikel
78 Pharmacokinetics of Extended-Release Dipyridamole following Administration through a Gastrostomy Tube Batista, Leonardo M.
2010
7 p. 483-488
artikel
79 Pharmacokinetic Study of Saxagliptin in Healthy Chinese Subjects Li, Haiyan
2012
7 p. 465-473
artikel
80 Pharmacological Anti-Remodelling Effects of Disease-Modifying Drugs in Heart Failure with Reduced Ejection Fraction Correale, Michele

7 p. 567-579
artikel
81 Phase 1 Study of the Effect of Icosapent Ethyl on Warfarin Pharmacokinetic and Anticoagulation Parameters Braeckman, Rene A.
2014
7 p. 449-456
artikel
82 Prehospital Adenosine Diphosphate Receptor Blocker Use, Culprit Artery Flow, and Mortality in STEMI: The MADDEC Study Hautamäki, Markus

7 p. 605-613
artikel
83 Preservative-Free Latanoprost Eye Drops in Patients with Primary Open-Angle Glaucoma/Ocular Hypertension Sanford, Mark
2014
7 p. 521-528
artikel
84 Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release Imanaka, Keiichiro
2014
7 p. 501-511
artikel
85 Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation Herranz-Pinto, Pedro

7 p. 517-527
artikel
86 Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naïve Patients with Chronic Lymphocytic Leukemia: An Italian Healthcare Administrative Database Analysis Ronconi, Giulia

7 p. 595-604
artikel
87 Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema Riedl, Marc
2015
7 p. 407-417
artikel
88 Relationship Between the Expression of O6-Methylguanine-DNA Methyltransferase (MGMT) and p53, and the Clinical Response in Metastatic Pancreatic Adenocarcinoma Treated with FOLFIRINOX Vitellius, Carole
2017
7 p. 669-677
artikel
89 Relative Bioavailability of Omecamtiv Mecarbil Pediatric Minitablet Formulations in Healthy Adult Subjects Trivedi, Ashit

7 p. 639-645
artikel
90 Response to “Acetazolamide and Cardiac Failure” Imiela, Tomasz
2018
7 p. 651
artikel
91 Response to “Comment on: Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety” Lee, Young R.

7 p. 661-662
artikel
92 Response to Sharma et al.: Long Pulmonary Residence Time and Plasma Half-Life of Tiotropium: Implications for Pharmacokinetic Bioequivalence Studies Algorta, Jaime
2017
7 p. 709-710
artikel
93 RETRACTED ​ARTICLE: Efficacy of Menatetrenone (Vitamin K2) against Non-Vertebral and Hip Fractures in Patients with Neurological Diseases Iwamoto, Jun
2009
7 p. 471-479
artikel
94 RETRACTED ARTICLE: Fetal Safety of Dydrogesterone Exposure in the First Trimester of Pregnancy Koren, Gideon

7 p. 679
artikel
95 Rifamycin SV MMX®: A Review in the Treatment of Traveller’s Diarrhoea Hoy, Sheridan M.

7 p. 691-697
artikel
96 Rifamycin SV MMX®: A Review in the Treatment of Traveller’s Diarrhoea Hoy, Sheridan M.

7 p. 691-697
artikel
97 Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral Doses Guo, Beining
2012
7 p. 475-486
artikel
98 Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials Wang, Fangfang

7 p. 503-515
artikel
99 Safety and Tolerability of an Olmesartan Medoxomil-Based Regimen in Patients with Stage 1 Hypertension Chrysant, Steven G.
2010
7 p. 473-482
artikel
100 Safety and Tolerability of an SQ-Standardized GRAss ALlergy Immunotherapy Tablet (GRAZAX®) in a Real-Life Setting for Three Consecutive Seasons — The GRAAL Trial Wessel, François
2012
7 p. 451-463
artikel
101 Safety, Pharmacokinetics, and Pharmacogenetics of Single-Dose Teriflunomide Sodium and Leflunomide in Healthy Chinese Subjects Yao, Xueting
2019
7 p. 643-651
artikel
102 Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses Nirogi, Ramakrishna

7 p. 603-615
artikel
103 Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men Yee, Ka Lai
2018
7 p. 631-638
artikel
104 Safety, Tolerability and Pharmacokinetics of Yimitasvir Phosphate Capsule, a Novel Oral Hepatitis C Virus NS5A Inhibitor, in Healthy Chinese Volunteers Zhao, Nan
2019
7 p. 671-681
artikel
105 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Inhaled Doses of Umeclidinium in Healthy Subjects: Two Randomized Studies Cahn, Anthony
2013
7 p. 477-488
artikel
106 Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Heart Failure Events in Patients with Type 2 Diabetes Mellitus: A Cost Per Outcome Analysis Arbel, Ronen

7 p. 665-669
artikel
107 Spontaneous and Immune Checkpoint Inhibitor-Induced Autoimmune Diseases: Analysis of Temporal Information by Using the Japanese Adverse Drug Event Report Database Ogawa, Keiko

7 p. 615-627
artikel
108 Steady-State Pharmacokinetics of Darunavir/Ritonavir and Pitavastatin when Co-administered to Healthy Adult Volunteers Yu, Christine Y.
2014
7 p. 475-482
artikel
109 Steady-State Pharmacokinetics of Darunavir/Ritonavir and Pitavastatin when Co-administered to Healthy Adult Volunteers Yu, Christine Y.

7 p. 475-482
artikel
110 Successful Empirical Antifungal Therapy of Intravenous Itraconazole with Pharmacokinetic Evidence in Pediatric Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation Kim, Hyery
2015
7 p. 437-446
artikel
111 Successful Intravenous Thrombolysis and Endovascular Treatment for Acute Ischemic Stroke in a Patient Pretreated with Ticagrelor: A Case Report and Literature Review Rizzo, Federica

7 p. 653-657
artikel
112 Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and Tolerability Hatalova, Katarina
2016
7 p. 591-598
artikel
113 Systematic Review of the Economic Evaluation of Sodium–Glucose Cotransporter-2 Inhibitors Used as Treatment in Patients with Heart Failure Nam, Kyungae

7 p. 463-474
artikel
114 Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib Versus Sunitinib for Previously Untreated Advanced Renal Cell Carcinoma Geynisman, Daniel M.

7 p. 611-622
artikel
115 The Cerebrospinal Fluid Distribution of Postoperatively Administred Dexketoprofen and Etoricoxib and Their Effect on Pain and Inflammatory Markers in Patients Undergoing Hip Arthroplasty Piirainen, Annika
2016
7 p. 545-555
artikel
116 The Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Ipragliflozin, a Novel Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor Zhang, Wenhui
2013
7 p. 489-496
artikel
117 The Effect of Rifampin on the Pharmacokinetics of Edoxaban in Healthy Adults Mendell, Jeanne
2015
7 p. 447-453
artikel
118 The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects Yee, Ka Lai
2017
7 p. 659-667
artikel
119 Thromboembolic Events While Taking Direct Oral Anticoagulants: An Analysis of Post-market WHO Database Reports from 2012 to 2020 Mitrovic, Darko

7 p. 593-598
artikel
120 Tolerability and Pharmacokinetics of Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor-γ Agonist, After a Single Oral Administration in Healthy Female Subjects Park, Min Kyu
2014
7 p. 467-474
artikel
121 Translating Benzodiazepine Utilization Data into Meaningful Population Exposure: Integration of Two Metrics for Improved Reporting Brandt, Jaden
2018
7 p. 565-572
artikel
122 Treatment of Morton Neuroma with Botulinum Toxin A: A Pilot Study Climent, José M.
2013
7 p. 497-503
artikel
123 Treatment of Severe Hypertriglyceridemia-Induced Acute Pancreatitis with Subcutaneous Insulin: Case Report Lee, Jeonghun

7 p. 671-674
artikel
124 Twenty-Four-Hour Ambulatory Blood Pressure Reduction with a Perindopril/Amlodipine Fixed-Dose Combination Nagy, Viktor L.
2013
7 p. 469-476
artikel
125 Vortioxetine versus Duloxetine in the Treatment of Patients with Major Depressive Disorder: A Meta-Analysis of Randomized Controlled Trials Li, Guangjian
2016
7 p. 509-517
artikel
                             125 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland